New Key Statistics Module, Z-Score and F-Score
NAS:BCRX Key Ratios
| Market Cap $ M | 1,681.98 |
| Enterprise Value $ M | 2,247.14 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 4.27 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 382.00 |
| EPS (TTM) $ | -0.73 |
| Beneish M-Score | 9.91 |
| 10-y EBITDA Growth Rate % | -4.10 |
| 5-y EBITDA Growth Rate % | 6.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -49.57 |
| EV-to-EBITDA | -51.23 |
| PEG | -- |
| Shares Outstanding M | 206.89 |
| Net Margin (%) | -38.18 |
| Operating Margin % | -15.78 |
| Pre-tax Margin (%) | -38.33 |
| Quick Ratio | 2.78 |
| Current Ratio | 2.82 |
| ROA % (ttm) | -29.07 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -81.68 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.97 |
BCRX Number of Guru Trades
BCRX Volume of Guru Trades
Gurus Latest Trades with NAS:BCRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BCRX is held by these investors
Total 1
BioCryst Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:BCRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers